1. Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Cummins E, Liu B, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 2012;206:1645-1651.
2. Barry C, Waring J, Stapledon R, Konstantinos A, National Tuberculosis Advisory Committee. Tuberculosis notifications in Australia, 2008 and 2009. Commun Dis Intell 2012;36:82-94.
3. Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th edn. Philadelphia, PA: Saunders Elsevier; 2008.
4. Hanna JN. The epidemiology of invasive Haemophilus influenzae infections in children under five years of age in the Northern Territory: a three-year study. Med J Aust 1990;152:234-240.
5. Markey P, Krause V, Boslego JW, Coplan PM, Dargan JM, Kaplan KM. The effectiveness of Haemophilus influenzae type b conjugate vaccines in a high risk population measured using immunization register data. Epidemiol Infect 2001;126:31-36.
6. Ulanova M, Tsang RS. Invasive Haemophilus influenzae disease: changing epidemiology and host–parasite interactions in the 21st century. Infect Genet Evol 2009;9:594-605.
7. Jacups SP, Morris PS, Leach AJ. Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras. Vaccine 2011;29:3083-3088.
8. Guthridge S, McIntyre P, Isaacs D, Hanlon M, Patel M. Differing serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in Australian Aboriginal and Caucasian infants – implications for disease epidemiology. Vaccine 2000;18:2584-2591.
9. National Health and Medical Research Council (NHMRC). The Australian Immunisation Handbook. 9th edn. Canberra: Australian Government Department of Health and Ageing; 2008.
10. Galil K, Singleton R, Levine OS, Fitzgerald MA, Bulkow L, Getty M, et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999;179:101-106.
11. Greenberg DP, Doemland M, Bettinger JA, Scheifele DW, Halperin SA, Waters V, et al. Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States. Pediatr Infect Dis J 2009;28:521-528.
12. Wilson N, Wenger J, Mansoor O, Baker M, Martin D. The beneficial impact of Hib vaccine on disease rates in New Zealand children. N Z Med J 2002;115:U122.
13. Menzies R, Turnour C, Chiu C, McIntyre P. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 2003 to 2006. Commun Dis Intell 2008;32 Suppl:S2-S67.
14. Markey P. Nearing elimination of hepatitis A in the Northern Territory following immunisation of Indigenous infants. North Territory Dis Control Bull 2010;17(3):1-6.
15. OzFoodNet Working Group. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet Network, 2009. Commun Dis Intell 2010;34:396-426.
16. NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2010: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2012;36:1-69.
17. Donnan EJ, Fielding JE, Gregory JE, Lalor K, Rowe S, Goldsmith P, et al. A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009. Clin Infect Dis 2012;54:775-781.
18. Singleton R, Holve S, Groom A, McMahon BJ, Santosham M, Brenneman G, et al. Impact of immunizations on the disease burden of American Indian and Alaska Native children. Arch Pediatr Adolesc Med 2009;163:446-453.
19. Aratchige PE, Markey P, Webby R, Krause V. Hepatitis B in the Northern Territory – an analysis of hepatitis B notifications. North Territory Dis Control Bull 2012;19(2):1-12.
20. Wan X, Mathews JD. Primary hepatocellular carcinoma in Aboriginal Australians. Aust J Public Health 1994;18:286-290.
21. Wood N, McIntyre P, Singh G, Sayers S. Predictors of hepatitis B immunity in Aboriginal children: the Australian Aboriginal Birth Cohort Study. Abstract presented at The Royal Australasian College of Physicians, Paediatrics and Child Health Division, Annual Scientific Meeting; 2008; Melbourne. J Paediatr Child Health 2008;44:A1.
22. Carroll E, Page W, Davis JS. Screening for hepatitis B in East Arnhem Land: a high prevalence of chronic infection despite incomplete screening. Intern Med J 2010;40:784-787.
23. Dent E, Selvey CE, Bell A, Davis J, McDonald MI. Incomplete protection against hepatitis B among remote Aboriginal adolescents despite full vaccination in infancy Commun Dis Intell 2010;34:435-439.
24. Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D, et al. Vaccine preventable diseases in Australia, 2005 to 2007. Commun Dis Intell 2010;34 Suppl:S1-S167.
25. Liu B, Guthridge S, Li SQ, Markey P, Krause V, McIntyre P, et al. The end of the Australia antigen? An ecological study of the impact of universal newborn hepatitis B vaccination two decades on. Vaccine 2012;30:7309-7314.
26. Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. 10th edn. Canberra: Australian Government Department of Health and Ageing; 2013.
27. Wallace P. Chapter 4: H1N1 2009 infections in Australia’s Indigenous population 2009 (thesis chapter). Canberra: Australian National University; 2011.
28. Bishop JF, Murnane MP, Owen R. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med 2009;361:2591-2594.
29. Carcione D, Giele C, Dowse GK, Mak DB, Goggin L, Kwan K, et al. Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg Infect Dis 2010;16:1388-1395.
30. Australian Government Department of Health and Ageing. Review of Australia’s health sector response to pandemic (H1N1) 2009: lessons identified. 2011. Accessed on 30 January 2013. Available from: www.flupandemic.gov.au/internet/panflu/publishing.nsf/Content/review-2011-l.
31. Herceg A, Sharp PG, Arthur CG, Tongs JA. Pandemic (H1N1) 2009 influenza in an urban Aboriginal medical service (letter). Med J Aust 2010;192:623.
32. Rudge S, Massey PD. Responding to pandemic (H1N1) 2009 influenza in Aboriginal communities in NSW through collaboration between NSW Health and the Aboriginal community-controlled health sector. N S W Public Health Bull 2010;21:26-29.
33. Flint SM, Davis JS, Su JY, Oliver-Landry EP, Rogers BA, Goldstein A, et al. Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia’s Northern Territory. Med J Aust 2010;192:617-622.
34. La Ruche G, Tarantola A, Barboza P, Vaillant L, Gueguen J, Gastellu-Etchegorry M. The 2009 pandemic H1N1 influenza and Indigenous populations of the Americas and the Pacific. Euro Surveill 2009;14(42):pii=19366.
35. Kelly H, Mercer GN, Cheng AC. Quantifying the risk of pandemic influenza in pregnancy and Indigenous people in Australia in 2009. Euro Surveill 2009;14(50):pii=19441.
36. Australian Institute of Health and Welfare (AIHW). Australia’s health 2010. Australia’s health series no. 12. Cat. No. AUS 122. Canberra: AIHW, 2010.
37. Trauer JM, Laurie KL, McDonnell J, Kelso A, Markey PG. Differential effects of pandemic (H1N1) 2009 on remote and Indigenous groups, Northern Territory, Australia, 2009. Emerg Infect Dis 2011;17:1615-1623.
38. Bish A, Yardley L, Nicoll A, Michie S. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine 2011;29:6472-6484.
39. Australian Institute of Health and Welfare (AIHW). 2010 Pandemic vaccination survey: summary results. Cat. No. PHE 128. Canberra: AIHW, 2010.
40. Zell ER, Ezzati-Rice TM, Battaglia MP, Wright RA. National Immunization Survey: the methodology of a vaccination surveillance system. Public Health Rep 2000;115:65-77.
41. Mak DB, Daly AM, Armstrong PK, Effler PV. Pandemic (H1N1) 2009 influenza vaccination coverage in Western Australia. Med J Aust 2010;193:401-404.
42. Patel M, Lush D. Measles vaccine effectiveness in Central Australian Aboriginal children vaccinated at or after eight months of age. Aust N Z J Public Health 1998;22:729-730.
43. Heywood AE, Gidding HF, Riddell MA, McIntyre PB, MacIntyre CR, Kelly HA. Elimination of endemic measles transmission in Australia. Bull World Health Organ 2009;87:64-71.
44. Burgess P, Markey P. Measles cases in Darwin June 2011. North Territory Dis Control Bull 2011;18(4):4-6.
45. Rosewell A, Reinten-Reynolds T, Spokes PJ. Measles in NSW, 2002–2011. N S W Public Health Bull 2012;23:201-207.
46. Martin N, Foxwell AR. Measles status in Australia, and outbreaks in the first quarter of 2009. (published erratum appears in Commun Dis Intell 2010;34:152). Commun Dis Intell 2009;33:225-231.
47. Khatami A, Pollard AJ. The epidemiology of meningococcal disease and the impact of vaccines (published erratum appears in Expert Rev Vaccines 2011;10:398) Expert Rev Vaccines 2010;9:285-298.
48. Lennon D, Reid S, Stewart J, Jackson C, Crengle S, Percival T. Reducing inequalities with vaccines: New Zealand’s MeNZB vaccine initiative to control an epidemic. J Paediatr Child Health 2012;48:193-201.
49. Bangor-Jones RD, Dowse GK, Giele CM, van Buynder PG, Hodge MM, Whitty MM. A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Aust 2009;191:398-401.
50. Coleman K, Markey P, Krause V. Mumps in the NT. North Territory Dis Control Bull 2008;15(4):11-17.
51. Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, et al. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 2012;86:615-620.
52. Choi KM. Reemergence of mumps. Korean J Pediatr 2010;53:623-628.
53. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008;358:1580-1589.
54. Fisman DN, Tang P, Hauck T, Richardson S, Drews SJ, Low DE, et al. Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling. BMC Public Health 2011;11:694.
55. Roehr B. Whooping cough outbreak hits several US states. BMJ 2010;341:c4627.
56. Sin MA, Zenke R, R÷nckendorf R, Littmann M, Jorgensen P, Hellenbrand W. Pertussis outbreak in primary and secondary schools in Ludwigslust, Germany demonstrating the role of waning immunity. Pediatr Infect Dis J 2009;28:242-244.
57. World Health Organization (WHO). Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010;85:385-400.
58. King AJ, van Gorkom T, van der Heide HG, Advani A, van der Lee S. Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift? BMC Genomics 2010;11:64.
59. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008;6:288-301.
60. Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, RŘckinger S, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010;51:692-699.
61. Atkinson W, Wolfe C, Hamborsky J, editors. Epidemiology and prevention of vaccine-preventable diseases. 12th edn. Washington, D.C.: Public Health Foundation; 2011.
62. Bogaert D, de Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004;4:144-154.
63. Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th edn. Philadelphia: Churchill Livingstone; 2010.
64. Leibovitz E. Acute otitis media in pediatric medicine: current issues in epidemiology, diagnosis, and management. Paediatr Drugs 2003;5 Suppl 1:1-12.
65. Menzies RI, Singleton RJ. Vaccine preventable diseases and vaccination policy for Indigenous populations. Pediatr Clin North Am 2009;56:1263-1283.
66. Fagan RL, Hanna JN, Messer RD, Brookes DL, Murphy DM. The epidemiology of invasive pneumococcal disease in children in Far North Queensland. J Paediatr Child Health 2001;37:571-575.
67. Giele C, Moore H, Bayley K, Harrison C, Murphy D, Rooney K, et al. Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia? Vaccine 2007;25:2379-2384.
68. Krause VL, Reid SJ, Merianos A. Invasive pneumococcal disease in the Northern Territory of Australia, 1994–1998. Med J Aust 2000;173 Suppl:S27-S31.
69. Lehmann D, Willis J, Moore HC, Giele C, Murphy D, Keil AD, et al. The changing epidemiology of invasive pneumococcal disease in Aboriginal and non-Aboriginal Western Australians from 1997 through 2007 and emergence of nonvaccine serotypes. Clin Infect Dis 2010;50:1477-1486.
70. Fitzwater SP, Chandran A, Santosham M, Johnson HL. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2012;31:501-508.
71. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 2010;14:e197-e209.
72. Kaplan SL, Barson WJ, Lin PL, Stovall SH, Bradley JS, Tan TQ, et al. Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics 2010;125:429-436.
73. Moore MR, Gertz RE, Jr., Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008;197:1016-1027.
74. Giele CM, Keil AD, Lehmann D, Van Buynder PG. Invasive pneumococcal disease in Western Australia: emergence of serotype 19A (letter). Med J Aust 2009;190:166.
75. Hanna JN, Humphreys JL, Murphy DM. Invasive pneumococcal disease in Indigenous people in north Queensland: an update, 2005–2007. Med J Aust 2008;189:43-46.
76. Krause V, Cook H. Downs and ups of invasive pneumococcal disease (IPD) amid vaccine introductions in the Indigenous population of the Northern Territory, Australia. In: Abstracts from 8th International Symposium on Pneumococci and Pneumococcal Diseases; 2012 Mar 11–15; Iguašu Falls, Brazil. Available from: www2.kenes.com/ISPPD/Scientific/Documents/FinalAbstractbook.pdf
77. Said MA, O’Brien KL, Nuorti JP, Singleton R, Whitney CG, Hennessy TW. The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations. Vaccine 2011;29:5355-5362.
78. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007;297:1784-1792.
79. Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, et al. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease. Clin Infect Dis 2010;50:1238-1246.
80. Cook H, Markey P, O’Hare S, Smith HV, Tindall H, Yip TW, et al. A lengthy widespread outbreak of serotype-1 invasive pneumococcal disease shows protection with the 10-valent conjugate vaccine and increased pneumonia complications. In: Abstracts from 8th International Symposium on Pneumococci and Pneumococcal Diseases; 2012 Mar 11–15; Iguašu Falls, Brazil. Available from: www2.kenes.com/ISPPD/Scientific/Documents/FinalAbstractbook.pdf
81. Einsiedel LJ, Fernandes LA, Woodman RJ. Racial disparities in infection-related mortality at Alice Springs Hospital, Central Australia, 2000–2005. Med J Aust 2008;188:568-571.
82. Menzies R, McIntyre P. Vaccine preventable diseases and vaccination policy for Indigenous populations. Epidemiol Rev 2006;28:71-80.
83. Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422. doi:000410.001002/14651858.CD14000422.pub14651852.
84. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005;365:1139-1146.
85. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce NF. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-1348.
86. Jardine A, Menzies R, McIntyre P. Impact of pneumococcal conjugate vaccination on hospitalisation for respiratory infections in the Australian Indigenous population. In: Presentations from 7th International Symposium on Pneumococci and Pneumococcal Diseases; 2010 Mar 14–18; Tel Aviv, Israel. Available from: www.multiwebcast.com/isppd/2010/7th/4641/peter.mcintyre.the.impact.of.pneumococcal.conjugate.vaccination.on.html
87. Moore HC, Lehmann D, de Klerk N, Jacoby P, Richmond PC. Reduction in disparity for pneumonia hospitalisations between Australian Indigenous and non-Indigenous children. J Epidemiol Community Health 2012;66:489-494.
88. O’Grady KF, Carlin JB, Chang AB, Torzillo PJ, Nolan TM, Ruben A, et al. Effectiveness of 7-valent pneumococcal conjugate vaccine against radiologically diagnosed pneumonia in Indigenous infants in Australia. Bull World Health Organ 2010;88:139-146.
89. O’Grady KF, Lee KJ, Carlin JB, Torzillo PJ, Chang AB, Mulholland EK, et al. Increased risk of hospitalization for acute lower respiratory tract infection among Australian Indigenous infants 5–23 months of age following pneumococcal vaccination: a cohort study. Clin Infect Dis 2010;50:970-978.
90. Jardine A, Menzies RI, Deeks SL, Patel MS, McIntyre PB. The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia. Pediatr Infect Dis J 2009;28:761-765.
91. Leach AJ, Morris PS. The burden and outcome of respiratory tract infection in Australian and Aboriginal children. Pediatr Infect Dis J 2007;26(10 Suppl):S4-S7.
92. Moore H. Acute lower respiratory infections (ALRI) in Indigenous and non-Indigenous children. Australasian Epidemiologist 2011;18:15-20.
93. Torzillo P, Dixon J, Manning K, Hutton S, Gratten M, Hueston L, et al. Etiology of acute lower respiratory tract infection in Central Australian Aboriginal children. Pediatr Infect Dis J 1999;18:714-721.
94. Moffitt KL, Malley R. Next generation pneumococcal vaccines. Curr Opin Immunol 2011;23:407-413.
95. Campbell SJ, Nissen MD, Lambert SB. Rotavirus epidemiology in Queensland during the pre-vaccine era. Commun Dis Intell 2009;33:204-208.
96. Schultz R. Rotavirus gastroenteritis in the Northern Territory, 1995–2004. Med J Aust 2006;185:354-356.
97. Lambert SB, Faux CE, Hall L, Birrell FA, Peterson KV, Selvey CE, et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust 2009;191:157-160.
98. Macartney KK, Porwal M, Dalton D, Cripps T, Maldigri T, Isaacs D, et al. Decline in rotavirus hospitalisations following introduction of Australia’s national rotavirus immunisation programme. J Paediatr Child Health 2011;47:266-270.
99. Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010;126:e506-e512.
100. Dey A, Wang H, Menzies R, Macartney K. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Med J Aust 2012;197:453-457.
101. Desai R, Haberling D, Holman RC, Singleton RJ, Cheek JE, Groom AV, et al. Impact of rotavirus vaccine on diarrhea-associated disease burden among American Indian and Alaska Native children. Pediatrics 2012;129:e907-e913.
102. Snelling TL, Schultz R, Graham J, Roseby R, Barnes GL, Andrews RM, et al. Rotavirus and the Indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. Clin Infect Dis 2009;49:428-431.
103. Snelling TL, Andrews RM, Kirkwood CD, Culvenor S, Carapetis JR. Case-control evaluation of the effectiveness of the G1P(8) human rotavirus vaccine during an outbreak of rotavirus G2P(4) infection in central Australia. Clin Infect Dis 2011;52:191-199.
104. Marshall H, Ryan P, Roberton D. Uptake of varicella vaccine—a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation. Vaccine 2005;23:5389-5397.
105. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965;58:9-20.
106. Heywood AE, Macartney KK. How can we better understand trends in varicella zoster virus-related disease epidemiology? Med J Aust 2011;194:268-269.
107. Gordon CL, Fagan P, Hennessy J, Baird R. Characterization of Corynebacterium diphtheriae isolates from infected skin lesions in the Northern Territory of Australia. J Clin Microbiol 2011;49:3960-3962.
108. Communicable Diseases Network Australia, Australian Government Department of Health and Ageing. National Communicable Diseases Surveillance Report. Fortnight 10, 2011. Summary notes for selected diseases, 7 to 20 May 2011. Accessed on 15 February 2013. Available from: www.health.gov.au/internet/main/publishing.nsf/Content/cdnareport-fn10-11.htm
109. Stewardson AJ, Roberts JA, Beckett CL, Prime HT, Loh PS, Thorley BR, et al. Imported case of poliomyelitis, Melbourne, Australia, 2007. Emerg Infect Dis 2009;15:63-65.
110. D’Souza RM, Kennett M, Watson C. Australia declared polio free. Commun Dis Intell 2002;26:253-260.
111. Gautret P, Wilder-Smith A. Vaccination against tetanus, diphtheria, pertussis and poliomyelitis in adult travellers. Travel Med Infect Dis 2010;8:155-160.
112. Song N, Gao Z, Wood JG, Hueston L, Gilbert GL, MacIntyre CR, et al. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination. Vaccine 2012;30:4073-4078.
113. Zurynski Y, Elliott EJ. Australian Paediatric Surveillance Unit annual report, 2010. Commun Dis Intell 2011;35:244-249.
114. Hunt JM, Lumley J. Top End rural and remote Indigenous women: an Australian population group vulnerable to rubella. Commun Dis Intell 2004;28:499-503.
115. Hull BP, McIntyre PB, Heath TC, Sayer GP. Measuring immunisation coverage in Australia: a review of the Australian Childhood Immunisation Register. Aust Fam Physician 1999;28:55-60.
116. ED, Sam GA, Mead C. Methodology for measuring Australia’s childhood immunisation coverage. Commun Dis Intell 1998;22:36-37.
117. Australian Institute of Health and Welfare (AIHW). 2009 Adult vaccination survey: summary results. Cat. No. PHE 135. Canberra: AIHW, 2011.
118. Brotherton J, Gertig D, Chappell G, Rowlands L, Saville M. Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18–26 years from the National HPV Vaccination Program Register. Commun Dis Intell 2011;35:197-201.
119. Gertig DM, Brotherton JM, Saville M. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health 2011;8:171-178.
120. Brotherton JM, Deeks SL, Campbell-Lloyd S, Misrachi A, Passaris I, Peterson K, et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell 2008;32:457-461.
121. Australian Government Department of Health and Ageing. Immunise Australia Program. Human papillomavirus (HPV). 2013. Accessed on 14 January 2013. Available from: www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-hpv.
122. Northern Territory Centre for Disease Control. Change to Northern Territory childhood vaccination schedule 1 October 2009. North Territory Dis Control Bull 2009;16(3):14-15.
123. Wooten KG, Luman ET, Barker LE. Socioeconomic factors and persistent racial disparities in childhood vaccination. Am J Health Behav 2007;31:434-445.
124. Lindley MC, Groom AV, Wortley PM, Euler GL. Status of influenza and pneumococcal vaccination among older American Indians and Alaska Natives. Am J Public Health 2008;98:932-938.
125. Traeger M, Thompson A, Dickson E, Provencio A. Bridging disparity: a multidisciplinary approach for influenza vaccination in an American Indian community. Am J Public Health 2006;96:921-925.
126. Abbott P, Menzies R, Davison J, Moore L, Wang H. Immunisation calendars – improving vaccination timeliness in urban Aboriginal children. BMC Public Health 2013;Submitted.
127. Spurling GK, Hayman NE, Cooney AL. Adult health checks for Indigenous Australians: the first year’s experience from the Inala Indigenous Health Service. Med J Aust 2009;190:562-564.
128. O’Grady KA, Krause V, Andrews R. Immunisation coverage in Australian Indigenous children: time to move the goal posts. Vaccine 2009;27:307-312.
129. Loring BJ, Curtis ET. Routine vaccination coverage of 11 year olds, by ethnicity, through school-based vaccination in South Auckland. N Z Med J 2009;122:14-21.
130. Helme S, Lamb S. Closing the school completion gap for Indigenous students. Resource sheet no. 6 for the Closing the Gap Clearinghouse, Australian Institute of Health and Welfare and Australian Institute of Family Studies. 2011. Accessed on 14 January 2013. Available from: www.aihw.gov.au/closingthegap/documents/resource_sheets/ctgc-rs06.pdf.
131. Marshall HS, Richmond PC, Nissen MD, Jiang Q, Anderson AS, Jansen KU, et al. Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18–36 months: a phase 1 randomized-controlled clinical trial. Pediatr Infect Dis J 2012;31:1061-1068.
132. Menzies R, McIntyre P, Beard F. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002. Commun Dis Intell 2004;28 Suppl 1:S1-S45.
133. Australian Institute of Health and Welfare (AIHW). Improving the quality of Indigenous identification in hospital separations data. Cat. No. HSE 101. Health Services Series No. 25. Canberra: AIHW, 2005.
134. Australian Bureau of Statistics (ABS), Australian Institute of Health and Welfare (AIHW). The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples, 2005. Cat. No. 4704.0. Canberra: ABS, 2005.
135. Rank C, Menzies RI. How reliable are Australian Childhood Immunisation Register coverage estimates for Indigenous children? An assessment of data quality and coverage. Commun Dis Intell 2007;31:283-287.
136. Australian Institute of Health and Welfare (AIHW). Indigenous identification in hospital separations data: quality report. Cat. No. HSE 85. Health Services Series No. 35. Canberra: AIHW, 2010.
137. Public Health Committee, National Health and Medical Research Council (NHMRC). Surveillance case definitions. Canberra: NHMRC, 1994.
138. Communicable Diseases Network Australia. Australian national notifiable diseases and case definitions. Accessed on 20 January 2013. Available from: www.health.gov.au/internet/main/publishing.nsf/Content/cdna-casedefinitions.htm.
139. Australian Institute of Health and Welfare (AIHW). Australian hospital statistics 2010–11. Cat. No. HSE 117. Health Services Series No. 43. Canberra: AIHW, 2012.
140. McIntyre P, Amin J, Gidding H, Hull B, Torvaldsen S, Tucker A, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1993–1998. Commun Dis Intell 2000;24 Suppl:v-S83.
141. McIntyre P, Gidding H, Gilmour R, Lawrence G, Hull B, Horby P, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Commun Dis Intell 2002;26 Suppl:1-111.
142. Brotherton J, McIntyre P, Puech M, Wang H, Gidding H, Hull B, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2001 to 2002. Commun Dis Intell 2004;28 Suppl 2:vii-S116.
143. Brotherton J, Wang H, Schaffer A, Quinn H, Menzies R, Hull B, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Commun Dis Intell 2007;31 Suppl:S1-152.
144. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011;11:39-44.
145. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011;377:2085-2092.
146. Australian Institute of Health and Welfare (AIHW). Indigenous identification in hospital separations data: quality report. Cat. No. IHW 90. Canberra: AIHW, 2013.
147. O’Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM. Measuring diagnoses: ICD code accuracy. Health Serv Res 2005;40:1620-1639.
148. Australian Bureau of Statistics (ABS). Causes of death: Australia, 2010. Cat. No. 3303.0. Canberra: ABS, 2012. Accessed on 20 January 2013. Available from: www.abs.gov.au/AUSSTATS/abs@.nsf/allprimarymainfeatures/F941C630073EA7A8CA257B2E000D80F0?opendocument.
149. Australian Institute of Health and Welfare (AIHW). Mortality over the twentieth century in Australia: trends and patterns in major causes of death. Cat. No. PHE 73. Mortality Surveillance Series No. 4. Canberra: AIHW, 2006.
150. Carvalho FL, Cordeiro JA, Cury PM. Clinical and pathological disagreement upon the cause of death in a teaching hospital: analysis of 100 autopsy cases in a prospective study. Pathol Int 2008;58:568-571.
151. Kotovicz F, Mauad T, Saldiva PH. Clinico-pathological discrepancies in a general university hospital in SŃo Paulo, Brazil. Clinics 2008;63:581-588.
152. Crowcroft NS, Andrews N, Rooney C, Brisson M, Miller E. Deaths from pertussis are underestimated in England. Arch Dis Child 2002;86:336-338.
153. Sutter RW, Cochi SL, Brink EW, Sirotkin BI. Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979–1984. Am J Epidemiol 1990;131:132-142.
154. Australian Institute of Health and Welfare (AIHW). Principles on the use of direct age-standardisation in administrative data collections: for measuring the gap between Indigenous and non-Indigenous Australians. Cat. No. CSI 12. Canberra: AIHW, 2011.
155. Draper G, Turrell G, Oldenburg B. Health inequality in Australia: mortality. Health Inequalities Monitoring Series Number 1. AIHW Cat. No. PHE 55. Canberra: Queensland University of Technology and Australian Institute of Health and Welfare, 2004.
156. Australian Bureau of Statistics (ABS). Experimental estimates and projections, Aboriginal and Torres Strait Islander Australians, 1991 to 2021. Cat. No. 3238.0. Canberra: ABS, 2009. Accessed on 30 January 2013. Available from: www.abs.gov.au/ausstats/abs@.nsf/mf/3238.0.
157. Hull B, Dey A, Mahajan D, Menzies R, McIntyre PB. Immunisation coverage annual report, 2009. Commun Dis Intell 2011;35:132-148.
158. Hull BP, McIntyre PB. Immunisation coverage reporting through the Australian Childhood Immunisation Register – an evaluation of the third-dose assumption. Aust N Z J Public Health 2000;24:17-21.
159. Hull BP, Lawrence GL, MacIntyre CR, McIntyre PB. Estimating immunisation coverage: is the ‘third dose assumption’ still valid? Commun Dis Intell 2003;27:357-361.
160. Hull BP, Mahajan D, Dey A, Menzies RI, McIntyre PB. Immunisation coverage annual report, 2008. Commun Dis Intell 2010;34:241-258.
161. NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2009: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2011;35:61-131.
162. Commonwealth Department of Health and Aged Care. Measuring remoteness: Accessibility/Remoteness Index of Australia (ARIA). Revised edition. Occasional papers: new series number 14. Canberra: Department of Health and Aged Care, 2001. Available from: www.health.gov.au/internet/main/publishing.nsf/Content/health-historicpubs-hfsocc-ocpanew14a.htm.
163. Hull BP, Lawrence GL, MacIntyre CR, McIntyre PB. Immunisation coverage in Australia corrected for under-reporting to the Australian Childhood Immunisation Register. Aust N Z J Public Health 2003;27:533-538.
164. Vlack S, Foster R, Menzies R, Williams G, Shannon C, Riley I. Immunisation coverage of Queensland Indigenous two-year-old children by cluster sampling and by register. Aust N Z J Public Health 2007;31:67-72.
This publication is available as a downloadable document.